Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL

KLH carrier-protein

KLH carrier-protein vaccination containing no other protein or antibodies

Trial Locations (1)

80206

National Jewish Health, Denver

All Listed Sponsors
collaborator

Atopic Dermatitis and Vaccinia Network

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00614731 - Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route | Biotech Hunter | Biotech Hunter